| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e727909d17fde1129839931dba355e7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-2984 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 |
| filingDate |
1994-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_676b3dc0a3c6dc6d32d6eab68fe0b801 |
| publicationDate |
1995-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5419914-A |
| titleOfInvention |
Phospholipid analogue vesicle |
| abstract |
Delivery vehicle formulations comprising active agents encapsulated within microparticles which include a succinimidyl moiety extending externally from a lipid molecule therein are capable of the cytoplasmic or nuclear cell delivery of intact encapsulated active agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006222696-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5759519-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7829113-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8758810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011081404-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006099169-A3 |
| priorityDate |
1990-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |